Skip to main content
S&P 5007,786.77-0.19%DOW51,186.21+0.01%NASDAQ27,421.29-0.43%BTC$82,495.00-0.84%ETH$2,530.83-1.28%GOLD$4,149.60+0.21%OIL$92.28+4.53%
Smart Investors Daily
SID Premium
NV

NYSE · NVRO

Nevro Corp.

Healthcare · Medical - Devices

$5.84

Up+$0.00 (+0.00%)

Updated Oct 8, 2026, 2:16 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
224.09M
P/E ratio
-2.5
Dividend yield
0.00%
52-week range
— – —
Volume
751.5K
Avg. volume
1.3M

Price performance · NVRO

NVRO price history

1M range · 0 trading sessions · Daily adjusted prices

NVRO does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest NVRO news

The latest Smart Investors Daily articles mentioning NVRO.

Stock researchCompany · Overview

NVRO research

Overview

Company profile and research snapshot.

Company profile

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$30.32
Implied upside
—
Analysts
19
NVRO recent ratings
DateFirmRatingTarget
Feb 7, 2025Piper SandlerNeutral—
Feb 7, 2025Canaccord GenuityHold—
Dec 18, 2024Truist SecuritiesHold—
Dec 11, 2024Wells FargoEqual-Weight—
Dec 11, 2024CitigroupNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Nov 11, 2025

EnviroGold Retires Over $10.2 Million in Debt in 2025, Strengthens Balance Sheet as Commercialization Accelerates

VANCOUVER, British Columbia, Nov. 11, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold” or the “Company”) is pleased to announce the successful conversion and retirement of approximately $10.2 million in debt consisting of approximately $9.1 million in principal and $1.1 million in interest and costs during 2025. These actions eliminate all outstanding convertible and promissory liabilities from the Company's balance sheet, marking a major milestone for EnviroGold as it advances toward commercialization of its proprietary NVRO Process™.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By